Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis
- 31 October 2007
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 57 (4) , 725-727
- https://doi.org/10.1016/j.jaad.2007.07.010
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosisJournal of the American Academy of Dermatology, 2007
- Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin TherapyAnnals of Internal Medicine, 2006
- A Novel Role for Erythropoietin During Fibrin-Induced Wound-Healing ResponseThe American Journal of Pathology, 2003